Sutro Biopharma Inc (NASDAQ:STRO)

Delayed Data
As of 4:00pm ET
 +0.03 / +0.29%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Sutro Biopharma Inc have a median target of 19.00, with a high estimate of 23.00 and a low estimate of 16.00. The median estimate represents a +83.40% increase from the last price of 10.36.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Sutro Biopharma Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -24.18%
Growthannually 59.50%


Growthquarterly -18.93%
Growthannually 7.72%
Key to the earnings and sales forecast charts.